UNSPSC 51281608: Butikacin

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H45N5O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I61243PDCC, chemically known as uk-18,892 but generally known as butikacin, which bears US NIH Compound Identifier 65487. European Medicines Agency schedules Butikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06017MIG.

UNSPSC 51281608 Butikacin, a Commodity code, does not align with the recent state and local procurement opportunities tagged under it. The code nominally refers to a specific pharmaceutical compound, but the four recent opportunities solicited under this code span naloxone procurement, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products — none of which center on butikacin. The mismatch suggests either a classification error in the sourcing system or that the code is being used as a catch-all for pharmaceutical and medical-supply procurement more broadly. State and local governments are actively buying naloxone, emergency medical supplies, and generic pharmaceuticals through this code path, but the connection to butikacin specifically is unclear from the available opportunities.

The issuing-body mix includes county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments and purchasing offices (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota, Oregon, and other member jurisdictions). Recent activity concentrates in Florida, Texas, and Minnesota. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, response deadline July 26, 2023); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 (IFB 26P00145, response deadline March 13, 2026, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount); the Texas Health and Human Services Commission's RFI for direct-to-manufacturer pharmaceutical prescription program implementation (RFI HHS0017013, posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products across member jurisdictions (RFP S1070000015802, response deadline March 26, 2026).